Best Electrolytes for GLP-1 Users: Evidence-Based Picks for Hydration & Cramp Relief

Sodium is the principal extracellular cation and the primary determinant of plasma volume — the fluid in your blood vessels. When GLP-1 medications suppress appetite by 30–50%, dietary sodium intake drops proportionally; when they cause vomiting or diarrhea, additional sodium and fluid are lost through the gut. The combination predictably reduces plasma volume in a subset of users, which manifests as lightheadedness on standing, low-grade fatigue, and headache. Potassium is the principal intracellular cation and works alongside sodium to regulate cellular fluid balance and neuromuscular excitability. Potassium intake also drops with reduced food intake — particularly because the highest-potassium foods (fruits, vegetables, legumes, dairy) are often the foods GLP-1 users find easiest to skip when nausea is present. Low potassium contributes to fatigue and is a documented contributor to muscle cramping. Magnesium acts as a cofactor in over 300 enzymatic reactions, including ATP-dependent muscle relaxation. The combination of reduced magnesium intake (from reduced food intake) and the appetite-suppression-driven shift toward simpler, more processed foods (which are lower in magnesium than whole-food sources) creates a magnesium gap that is mechanistically aligned with night-time cramping. The glycinate form (in the Life Extension product) is easier on a GI tract already sensitive from GLP-1 effects than magnesium oxide, the form found in cheap mass-market electrolyte drinks. A critical caveat: the right total daily sodium for an individual on a GLP-1 medication depends on baseline blood pressure, kidney function, and concurrent medications. Adding 500–1,000 mg of sodium to a low-sodium baseline is reasonable for most healthy users with normotensive blood pressure and intact kidney function. The same addition in someone with stage 2 hypertension on diuretics or with stage 3 CKD is not reasonable. This is the part 'drink LMNT' marketing skips, and why we hedge this entire page heavily.

The single most important decision in electrolytes-for-GLP-1 shopping is not which brand you buy — it's whether you actually have a sodium intake problem worth solving. The GLP-1 user with normotensive blood pressure, normal kidney function, dramatically reduced appetite, and night-time muscle cramping is a near-textbook candidate for 300–500 mg of supplemental sodium per day. The GLP-1 user with stage 2 hypertension on a thiazide diuretic is the opposite — adding sodium is not a benign intervention. The two products on this page sit at the conservative end (320–500 mg sodium per serving) precisely because the GLP-1 audience is heterogeneous and one-size-fits-all sodium recommendations are not safe. Do not assume LMNT-tier sodium (1,000 mg per packet) is right for you. LMNT is formulated for athletes losing sweat sodium during sustained exertion, not for sedentary GLP-1 users with appetite suppression. The 1,000 mg dose is excessive for many GLP-1 users without active exercise, and it is dangerous for GLP-1 users with hypertension, heart failure, or CKD. The fact that LMNT is the most-marketed product to GLP-1 users on social media is a marketing fact, not a clinical one. Timing matters more than people expect. Take an electrolyte serving in the morning to set up the day's fluid balance, and a second one after exercise or in the evening if you experience night-time cramping. Do not chase nausea with electrolytes immediately — if you have active nausea, sipping plain water or oral rehydration solution in small quantities is gentler than an effervescent tablet. Watch for warning signs that go beyond what a consumer page can manage. Significant lightheadedness on standing, dark urine, reduced urine output, confusion, racing pulse, or persistent nausea/vomiting that prevents fluid intake are signs of significant dehydration or electrolyte derangement that need clinician evaluation — not more electrolyte powder. Food-first note: electrolyte supplementation does not replace adequate food intake. The most evidence-backed approach to managing the GLP-1 fatigue-cramp-headache cluster is working with your prescribing clinician on dose titration, anti-nausea strategy, and graduated reintroduction of nutrient-dense whole foods — particularly potassium-rich vegetables and adequate protein — that GLP-1-driven appetite suppression makes harder.